Neuraxial Steroid Injection in a Patient With a Mechanical Mitral Valve
61-year-old woman with 6 months of right L5 radicular pain after a fall. MRI shows a right L4–L5 disc extrusion with foraminal stenosis. She uses a cane and rates pain 8/10. Medical history: mechanical mitral valve replacement 4 years ago, atrial fibrillation, type 2 diabetes (A1c 9.1%), and stage 3b CKD (eGFR 42). Medications: warfarin (INR 2.4 today), aspirin 81 mg, metoprolol, insulin. She has no fever, weight loss, or bladder dysfunction. She requests a transforaminal epidural steroid injection to avoid surgery. Cardiology has not been consulted in 2 years.
1. What are the competing risks you must weigh before performing a transforaminal epidural steroid injection, and how do they affect your decision?
Read the worked answer
The main competing risks are spinal/epidural hematoma from neuraxial instrumentation while anticoagulated versus thromboembolism from interrupting warfarin in a patient with a mechanical mitral valve. A mechanical mitral valve is high thrombotic risk, so warfarin should not be stopped casually; cardiology should be involved and bridging considered. Transforaminal epidural injection is an intermediate-to-high bleeding-risk procedure, and concomitant aspirin adds little but does not usually require stopping. Her diabetes and CKD increase infection, steroid hyperglycemia, and renal risk. If her radicular pain is disabling but she has no progressive neurologic deficit, it is reasonable to postpone the injection until anticoagulation is formally managed or to choose conservative therapy. Shared decision-making and documentation are essential.
2. If, after cardiology clearance, the procedure is scheduled, outline the periprocedural anticoagulation and steroid plan, including monitoring.
Read the worked answer
For warfarin, a typical plan is to stop about 5 days before the procedure and confirm INR ≤1.4 on the day; if bridging is recommended by cardiology because of the mechanical valve, use LMWH and hold it at least 24 hours before the neuraxial procedure. Aspirin can generally continue. Check platelets and renal function, but routine coagulation testing beyond INR is not needed. Use a nonparticulate steroid such as dexamethasone 10 mg for transforaminal injection to reduce the risk of vascular occlusion and hyperglycemia. Monitor glucose closely for 1–2 weeks and counsel about adrenal suppression. Restart warfarin 24 hours after the procedure per cardiology, and observe for back pain, weakness, or bladder dysfunction.
3. What alternatives would you discuss if she and cardiology decide that interrupting warfarin is unacceptable?
Read the worked answer
Discuss a non-neuraxial approach: structured physical therapy, a supervised walking program, acetaminophen, and cautious use of topical NSAIDs rather than systemic NSAIDs because of CKD. A short course of oral corticosteroids is tempting but would be unsafe with poorly controlled diabetes and would not be repeated. If she has progressive weakness or cauda equina symptoms, surgical decompression after cardiology risk assessment may be necessary. For persistent radicular pain, refer to a multidisciplinary pain program and consider psychological support. Do not perform trigger-point or blind deep injections while fully anticoagulated, because bleeding risk remains. The decision should prioritize avoiding both epidural hematoma and valve thrombosis.